Weiheng Su

Sep 19, 2023 | insights.bio | Weiheng Su |Matt Roach

While the field of gene therapy continues to see success in the form of commercial approvals, the yields needed to meet the demands of these approvals has lagged. Newer, scalable production systems are needed to ensure that the production of products such as AAV can keep up with the clinical and commercial demand.